Importantly, activating FoxO3 using UCN-01 reversed the IPF myofibroblast phenotype in vitro and mitigated bleomycin-induced lung fibrosis in vivo. The gene discussed is FOXO3; the disease is idiopathic pulmonary fibrosis.